The Valley Desk

NCT00454779 · Interventional trial

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

Overall registry status Completed

Phase 2

Conditions Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov